Abstract
A 64-year-old man with CLL complicated by acquired hypogammaglobulinemia and COVID-19 pneumonia in 07/2020 was diagnosed with metastatic NSCLC in 08/2020 and underwent three cycles of pembrolizumab, resulting in stable disease. Frequent hospital admissions for respiratory failure with various infections including persistent COVID-19 positivity complicated his overall course. He received monthly IVIG infusions for hypogammaglobulinemia from 11/2020 to 12/2020 which were discontinued due to an allergic reaction.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
